Divi's Laboratories Limited (BOM:532488)

Market Cap	1.57T
Revenue (ttm)	96.52B
Net Income (ttm)	23.06B
Shares Out	n/a
EPS (ttm)	86.82
PE Ratio	68.09
Forward PE	57.95
Dividend	30.00 (0.47%)
Ex-Dividend Date	Jul 25, 2025

Volume	4,111
Average Volume	6,861
Open	6,420.05
Previous Close	6,493.15
Day's Range	6,366.30 - 6,525.00
52-Week Range	4,617.10 - 7,077.70
Beta	n/a
RSI	23.37
Earnings Date	Aug 7, 2025

About Model N

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its pro...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 10,542
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532488

Financial Performance

In 2024, Divi's Laboratories's revenue was 93.60 billion, an increase of 19.31% compared to the previous year's 78.45 billion. Earnings were 21.91 billion, an increase of 36.94%.